Calls
1
u/Odd-Sprinkles9774
Reddit r/smallstreetbets
Win Rate
0.0%
return
-49.5%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jun 16
$0.01
-49.5%
The author argues Aditxt’s new interim CEO Jeffrey Busch is pivoting from portfolio acquisitions to operational execution, focusing on commercializing Ignite Proteomics’ precision oncology diagnostics. The mechanism is converting Medicare reimbursement and Dana-Farber collaborations into recurring revenue to restore Nasdaq compliance. Catalyst/timeframe: the September 30, 2026 transaction deadline; main stated risk is failure to lift equity above Nasdaq limits, leading to an OTC pivot.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Odd-Sprinkles9774 has 1 trade ideas tracked on Buzzberg across 1 tickers since June 2026. Most covered: ADTX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
